Clinical characteristics and outcomes of people with severe mental disorders hospitalized due to COVID-19: A nationwide population-based study

被引:1
|
作者
Lopez-Cuadrado, Teresa [1 ,7 ]
Szmulewicz, Alejandro [2 ]
Ongur, Dost [3 ,6 ]
Martinez-Ales, Gonzalo [2 ,4 ,5 ]
机构
[1] Carlos III Hlth Inst, Natl Ctr Epidemiol, Dept Chron Dis Epidemiol, Madrid, Spain
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, CAUSALab, Boston, MA USA
[3] Harvard Med Sch, Dept Psychiat, Boston, MA USA
[4] Mental Hlth Network Biomed Res Ctr CIBERSAM, Madrid, Spain
[5] Hosp La Paz Inst Hlth Res IDIPaz, Madrid, Spain
[6] McLean Hosp, Psychot Disorders Div, Belmont, MA USA
[7] Carlos III Inst Hlth, Natl Ctr Epidemiol, C Monforte De Lemos 5, Madrid 28029, Spain
关键词
Severe mental illness; Hospital admissions; Mortality; COVID-19; ILLNESS; SCHIZOPHRENIA; MORTALITY; HEALTH; ANTIPSYCHOTICS; ASSOCIATION; DEPRESSION; PREVALENCE; ADMISSION; SMOKING;
D O I
10.1016/j.genhosppsych.2023.08.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objetive: Hospitalized COVID-19 patients with severe mental illness (SMI) have worse outcomes than counterparts without SMI. Barriers in access to acute care medical procedures among SMI patients may partially explain this phenomenon. Here, we examined differences in critical care admission and in-hospital mortality between hospitalized COVID-19 patients with and without SMI.Methods: This population-based study used Spain's nationwide electronic health records. Based on International Classification Diseases, Tenth Revision, ICD-10-CM codes, we identified all patients aged >15 years hospitalized due to COVID-19 between July 1st-December 31st, 2020, and compared patients with and without SMI in terms of (i) critical care admission and (ii) in-hospital mortality - overall and stratified by age. We used logistic regression models including sex, age, and comorbidity burden as measured by Charlson Comorbidity Index Score as covariates.Results: Of 118,691 hospital admissions due to COVID-19 of people aged >15 years, 1512 (1.3%) included a diagnosis of SMI. Compared to non-SMI patients, SMI patients had higher in-hospital mortality (OR,95%CI: 1.63,1.42-1.88) and were less frequently admitted to critical care (OR,95%CI: 0.70,0.58-0.85). Admission to critical care in SMI patients was lower than for non-SMI counterparts only among individuals aged >60 years. The magnitude of the difference in in-hospital mortality between SMI and non-SMI patients decreased as age increased.Conclusions: Individuals with SMI had reduced critical care admission and increased in-hospital mortality compared non-SMI counterparts, suggesting that differences in delivery of acute care medical procedures may partially explain higher risk of negative outcomes among COVID-19 patients with SMI.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 50 条
  • [31] Analysis of the Consequences of the COVID-19 Pandemic on People with Severe Mental Disorders
    Jose Sanchez-Guarnido, Antonio
    Hidalgo, Nuria
    de la Cruz, Jorge Arenas
    Esteban, Inmaculada
    Mondon, Silvia
    Herruzo, Carlos
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (16)
  • [32] Incidence of appendicitis during COVID-19 lockdown: A nationwide population-based study
    Jantzen, Amalie T.
    Bang-Nielsen, Anders
    Bertelsen, Claus A.
    Torp-Pedersen, Christian
    Kleif, Jakob
    SCANDINAVIAN JOURNAL OF SURGERY, 2022, 111 (02)
  • [33] Colchicine and risk of hospitalization due to COVID-19: A population-based study
    Saenz-Aldea, Maria
    Salgado-Barreira, Angel
    Trunk, Margarita Taracido
    Pineiro-Lamas, Maria
    Herdeiro, Maria T. T.
    Portela-Romero, Manuel
    Saez, Marc
    Figueiras, Adolfo
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [34] A nationwide dataset on the mental health of the Bangladeshi population due to the COVID-19 pandemic
    Islam, Md. Rabiul
    Daria, Sohel
    Das, Rajesh
    Hasan, Md. Rakib
    DATA IN BRIEF, 2021, 38
  • [35] Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study
    Rodriguez-Fernandez, Almudena
    Visos-Varela, Irene
    Zapata-Cachafeiro, Maruxa
    Pintos-Rodriguez, Samuel
    Garcia-Alvarez, Rosa M.
    Herdeiro, Teresa M.
    Pineiro-Lamas, Maria
    Figueiras, Adolfo
    Salgado-Barreira, Angel
    INFLAMMOPHARMACOLOGY, 2024, 32 (04) : 2305 - 2315
  • [36] The effect of COVID-19 pandemic on pregnancy outcomes - A Population-Based study
    Ben-Shmuel, Atar
    Berger, Howard
    Mei-Dan, Elad
    Melamed, Nir
    Barrett, Jon F.
    Aviram, Amir
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : S499 - S500
  • [37] Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea
    You, Ji Hong
    Lee, Sang Ah
    Chun, Sung-Youn
    Song, Sun Ok
    Lee, Byung-Wan
    Kim, Dae Jung
    Boyko, Edward J.
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (04) : 901 - 908
  • [38] MENTAL HEALTH OF PATIENTS HOSPITALIZED DUE TO COVID-19
    Glavina, Trpimir
    Marasovic, Tonka Borovina
    Zuljevic, Marija Franka
    Rakusic, Mihaela
    Mustapic, Marina
    Barisic, Tanja
    Uglesic, Boran
    Ivelja, Mirela Pavicic
    Kozina, Slavica
    Lasic, Davor
    Mastelic, Tonci
    CLINICAL NEUROPSYCHIATRY, 2023, 20 (06): : 479 - 485
  • [39] Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis
    Papaioannou, O.
    Karampitsakos, T.
    Tsiri, P.
    Sotiropoulou, V.
    Koulousousa, E.
    Tasiopoulos, P.
    Schinas, G.
    Katsaras, M.
    Zarkadi, E.
    Malakounidou, E.
    Georgiopoulou, V.
    Sampsonas, F.
    Spyridonidis, A.
    Akinosoglou, K.
    Marangos, M.
    Tzouvelekis, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7705 - 7712
  • [40] COVID-19 clinical outcomes and DMT of MS patients and population-based controls
    Longinetti, Elisa
    Bower, Hannah
    McKay, Kyla A.
    Englund, Simon
    Burman, Joachim
    Fink, Katharina
    Fogdell-Hahn, Anna
    Gunnarsson, Martin
    Hillert, Jan
    Langer-Gould, Annette
    Lycke, Jan
    Nilsson, Petra
    Salzer, Jonatan
    Svenningsson, Anders
    Mellergard, Johan
    Olsson, Tomas
    Piehl, Fredrik
    Frisell, Thomas
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (09): : 1449 - 1458